Georgina V. Long, BSc, PhD, MBBS | Authors

Articles

Activity of Dabrafenib/Trametinib Combo in Patients With Melanoma Brain Metastases

June 19, 2017

Georgina V. Long, BSc, PhD, MBBS, professor of medical melanoma oncology, Melanoma Institute Australia, discusses the activity seen with the combination of dabrafenib and trametinib for the treatment of patients with melanoma brain metastases.

Five-Year OS Data for Dabrafenib/Trametinib Combo in Melanoma

June 04, 2017

Georgina V. Long, BSc, PhD, MBBS, professor of medical melanoma oncology, Melanoma Institute Australia, discusses 5-year overall survival data from a phase II trial of dabrafenib (Tafinlar) and trametinib (Mekinist) in patients with BRAF V600-mutant unresectable or metastatic melanoma during the 2017 ASCO Annual Meeting.